Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome - Recall following different chemotherapy agents

Investigational New Drugs

Volumn 20, Issue 1, 2002, Pages 49-53

  Hui, Yuk Fung ^a   Giles, Francis J ^a   Cortes, Jorge E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Palmar; Plantar; Recall; Side effects; Troxacitabine

Indexed keywords

3 BENZYL 7 CYANO 2,3,4,5 TETRAHYDRO 1 (1H IMIDAZOL 4 YLMETHYL) 4 (2 THIENYLSULFONYL) 1H 1,4 BENZODIAZEPINE; 7 HYDROXYSTAUROSPORINE; ASPARAGINASE; CYCLOSPORIN; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DIMETHYL SULFOXIDE; DOLASTATIN; DOLASTATIN 10; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; METHOTREXATE; PYRIDOXINE; STEROID; TOPOTECAN; TROXACITABINE; VINCRISTINE;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DISEASE COURSE; DRUG STRUCTURE; FEMALE; HAND FOOT SYNDROME; HUMAN; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; REVIEW;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTOSINE; DIOXOLANES; ERYTHEMA; FEMALE; FOOT; HAND; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PARESTHESIA; RECURRENCE; SYNDROME;

EID: 0036203270     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014421912799     Document Type: Review

References (26)

1. Radiation recall and radiosensitization with alkylating agents
2. Reactivation of radiation pneumonitis by adriamycin
3. Pulmonary toxicity of antitumor agents
4. Cutaneous complications of chemotherapeutic agents
5. Potentiation of x-ray effects by actinomycin D
6. Dactinomycin potentiation of radiation pneumonitis: A forgotten interaction
7. Paclitaxelinduced radiation recall dermatitis
8. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel
9. Docetaxel and radiation-recall severe mucositis
10. Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome
11. Radiosensitization after busulphan
12. Radiation recall induced by tamoxifen
13. The new dioxolane, (-)-2′-deoxy-3′-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts
14. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo
15. Troxacitabine, (BCH-4556), a novel dioxolane nucleoside analog, has anti-leukemic activity
16. UCN-01 chemosensitizes human B-chronic lymphocytic leukemia (B-CLL) cells to the effects of fludarabine
17. Phase I study of tezacitabine, an antimetabolite deoxy-citidine analog, in patients with relapsed and refractory hematologic malignancies
18. Phase I study of dolastatin-10 in refractory or relapsed acute leukemia
19. Pharmacokinetics (PK) and pharmacodynamics (PD) of the farnesyltransferase (FT) inhibitor BMS-214662 in patients with advanced solid tumors
20. Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia
21. Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lympoblastic leukemia
22. Skin cell depletion: An explanation of the late effects of cytoxins
23. The "recall effect" in radiotherapy: Is subeffective, reparable damage involved?
24. Preclinial pharmacokinetics of beta-L-dioxolane-cytidine, a novel anticancer
25. Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells
26. Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia